These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7547085)

  • 1. The pharmacokinetics of tenidap sodium: introduction.
    Pullar T
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):1S-2S. PubMed ID: 7547085
    [No Abstract]   [Full Text] [Related]  

  • 2. Single and multiple dose pharmacokinetics of tenidap sodium in healthy subjects.
    Gardner MJ; Wilner KD; Hansen RA; Fouda HG; McMahon GF
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):11S-15S. PubMed ID: 7547086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of age and gender on the pharmacokinetics of tenidap sodium in patients with rheumatoid arthritis and osteoarthritis.
    Caldwell JR; Kirby DS; Gardner MJ; Hansen RA
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):3S-9S. PubMed ID: 7547091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tenidap sodium administered with food or antacid in healthy volunteers.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):17S-19S. PubMed ID: 7547087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine does not alter the clearance or plasma binding of tenidap in healthy male volunteers.
    Wilner KD; Gardner MJ
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):21S-24S. PubMed ID: 7547088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenidap sodium decreases renal clearance and increases steady-state concentrations of lithium in healthy volunteers.
    Apseloff G; Wilner KD; von Deutsch DA; Gerber N
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):25S-28S. PubMed ID: 7547089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenidap.
    Madhok R
    Lancet; 1995 Aug; 346(8973):481-5. PubMed ID: 7637484
    [No Abstract]   [Full Text] [Related]  

  • 8. A pharmacokinetic model for tenidap in normal volunteers and rheumatoid arthritis patients.
    Evans L; Aarons L; Coates P
    Pharm Res; 1999 Oct; 16(10):1608-15. PubMed ID: 10554105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model development and analysis of tenidap-induced proteinuria in the rat.
    Aleo MD; Wang T; Giebisch G; Sanders MJ; Walsh AH; Lopez-Anaya A
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1318-26. PubMed ID: 8968356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tenidap sodium on digoxin pharmacokinetics in healthy young men.
    Dewland PM; Grimwood VC; Rapeport WG; Coates PE
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):43S-46S. PubMed ID: 7547094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tenidap sodium on the disposition and plasma protein binding of phenytoin in healthy male volunteers.
    Blum RA; Schentag JJ; Gardner MJ; Wilner KD
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):35S-38S. PubMed ID: 7547092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers.
    Apseloff G; Wilner KD; Gerber N
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):29S-33S. PubMed ID: 7547090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. I. Mechanism and evidence of functional significance.
    McNiff P; Svensson L; Pazoles CJ; Gabel CA
    J Immunol; 1994 Sep; 153(5):2180-93. PubMed ID: 8051419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effect of tenidap on leukocyte-endothelial cell adhesion.
    Kyan-Aung U; Lee TH; Haskard DO
    J Rheumatol; 1993 Jun; 20(6):1014-9. PubMed ID: 8350307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of photosensitising potential of tenidap, a novel anti-rheumatic agent.
    Ferguson J; Leeming MR
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):63S-66S. PubMed ID: 7547098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenidap, an anti-inflammatory agent, discharges intracellular Ca++ store and inhibits Ca++ influx in cultured human gingival fibroblasts.
    Fujii A; Matsumoto H; Hashimoto T; Akimoto Y
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1447-52. PubMed ID: 8531115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tenidap on the anti-hypertensive efficacy of ACE inhibitors in patients treated for mild to moderate hypertension.
    Rapeport WG; Grimwood VC; Hosie J; Sloan PM; Korlipara K; Silvert BD; James I; Mechie GL; Anderton JL
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):57S-61S. PubMed ID: 7547097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
    McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tenidap on the anti-hypertensive efficacy of thiazide diuretics in patients treated for mild to moderate hypertension.
    Rapeport WG; Grimwood VC; Korlipara K; Grillage MG; James I; Anderton JL; Selfridge DI
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):51S-55S. PubMed ID: 7547096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.